Cutler Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-120
| Closed | -$1K | – | 1631 |
|
|
2023
Q4 | $1K | Hold |
120
| – | – | ﹤0.01% | 1239 |
|
|
2023
Q3 | $1K | Hold |
120
| – | – | ﹤0.01% | 1334 |
|
|
2023
Q2 | $1K | Hold |
120
| – | – | ﹤0.01% | 1311 |
|
|
2023
Q1 | $1K | Hold |
120
| – | – | ﹤0.01% | 1343 |
|
|
2022
Q4 | $1K | Hold |
120
| – | – | ﹤0.01% | 1656 |
|
|
2022
Q3 | $1K | Hold |
120
| – | – | ﹤0.01% | 1829 |
|
|
2022
Q2 | $1K | Sell |
120
-10
| -8% | -$83 | ﹤0.01% | 1803 |
|
|
2022
Q1 | $3K | Buy |
130
+10
| +8% | +$231 | ﹤0.01% | 1772 |
|
|
2021
Q4 | $3K | Hold |
120
| – | – | ﹤0.01% | 1891 |
|
|
2021
Q3 | $4K | Sell |
120
-150
| -56% | -$5K | ﹤0.01% | 1885 |
|
|
2021
Q2 | $11K | Buy |
270
+150
| +125% | +$6.11K | ﹤0.01% | 1692 |
|
|
2021
Q1 | $4K | Sell |
120
-766
| -86% | -$25.5K | ﹤0.01% | 1810 |
|
|
2020
Q4 | $31K | Buy |
886
+766
| +638% | +$26.8K | ﹤0.01% | 1142 |
|
|
2020
Q3 | $2K | Buy |
+120
| New | +$2K | ﹤0.01% | 1556 |
|
|
2019
Q2 | – | Sell |
-170
| Closed | -$4K | – | 2086 |
|
|
2019
Q1 | $4K | Sell |
170
-30
| -15% | -$706 | ﹤0.01% | 1319 |
|
|
2018
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 1394 |
|
|
2018
Q3 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 1369 |
|
|
2018
Q2 | – | Sell |
-530
| Closed | -$18K | – | 2153 |
|
|
2018
Q1 | $18K | Buy |
+530
| New | +$18K | ﹤0.01% | 1232 |
|
|
2017
Q1 | – | Sell |
-158
| Closed | -$3K | – | 3256 |
|
|
2016
Q4 | $3K | Sell |
158
-222
| -58% | -$4.22K | ﹤0.01% | 2596 |
|
|
2016
Q3 | $13K | Buy |
380
+370
| +3,700% | +$12.7K | ﹤0.01% | 2020 |
|
|
2016
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 3272 |
|
|
2016
Q1 | $0 | Buy |
+10
| New | – | ﹤0.01% | 3270 |
|